Synthetic glycans provide insight into the binding properties of toxic serum antibodies

Geert Jan Boons; Bart C. Jacobs

doi:10.1038/s44160-023-00395-3

Synthetic glycans provide insight into the binding properties of toxic serum antibodies

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

A chemoenzymatic strategy is introduced whereby a glycan backbone is assembled enzymatically to give a core oligosaccharide that is subjected to chemical manipulations to install terminal epitopes. A library of oligosaccharides
containing the human natural killer-1 epitope was synthesized, enabling evaluation of the binding specificities of serum antibodies of patients with anti-myelin-
associated glycoprotein neuropathy.

Original language	English
Pages (from-to)	15-16
Number of pages	2
Journal	Nature Synthesis
Volume	3
Issue number	1
Early online date	2 Oct 2023
DOIs	https://doi.org/10.1038/s44160-023-00395-3
Publication status	Published - Jan 2024

Access to Document

10.1038/s44160-023-00395-3

Cite this

@article{4121d43dd3124ec1ac23409bc7632520,

title = "Synthetic glycans provide insight into the binding properties of toxic serum antibodies",

abstract = "A chemoenzymatic strategy is introduced whereby a glycan backbone is assembled enzymatically to give a core oligosaccharide that is subjected to chemical manipulations to install terminal epitopes. A library of oligosaccharidescontaining the human natural killer-1 epitope was synthesized, enabling evaluation of the binding specificities of serum antibodies of patients with anti-myelin-associated glycoprotein neuropathy.",

author = "Boons, {Geert Jan} and Jacobs, {Bart C.}",

year = "2024",

month = jan,

doi = "10.1038/s44160-023-00395-3",

language = "English",

volume = "3",

pages = "15--16",

journal = "Nature Synthesis",

issn = "2731-0582",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Synthetic glycans provide insight into the binding properties of toxic serum antibodies

AU - Boons, Geert Jan

AU - Jacobs, Bart C.

PY - 2024/1

Y1 - 2024/1

N2 - A chemoenzymatic strategy is introduced whereby a glycan backbone is assembled enzymatically to give a core oligosaccharide that is subjected to chemical manipulations to install terminal epitopes. A library of oligosaccharidescontaining the human natural killer-1 epitope was synthesized, enabling evaluation of the binding specificities of serum antibodies of patients with anti-myelin-associated glycoprotein neuropathy.

AB - A chemoenzymatic strategy is introduced whereby a glycan backbone is assembled enzymatically to give a core oligosaccharide that is subjected to chemical manipulations to install terminal epitopes. A library of oligosaccharidescontaining the human natural killer-1 epitope was synthesized, enabling evaluation of the binding specificities of serum antibodies of patients with anti-myelin-associated glycoprotein neuropathy.

UR - http://www.scopus.com/inward/record.url?scp=85173118818&partnerID=8YFLogxK

U2 - 10.1038/s44160-023-00395-3

DO - 10.1038/s44160-023-00395-3

M3 - Article

AN - SCOPUS:85173118818

SN - 2731-0582

VL - 3

SP - 15

EP - 16

JO - Nature Synthesis

JF - Nature Synthesis

IS - 1

ER -

Synthetic glycans provide insight into the binding properties of toxic serum antibodies

Abstract

Access to Document

Other files and links

Fingerprint

Cite this